Condition
Cerebrospinal Fluid Leakage
Total Trials
5
Recruiting
2
Active
2
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05898074Not ApplicableRecruiting
Role of Novel RADA16 Hydrogel in Endoscopic Skull Base Surgery
NCT06419855TerminatedPrimary
Study to Evaluate the Effectivity and Safety of BIOSCAFF®H Compared to DuraGen®, in Patients Undergoing Dural Repair
NCT06472505Not ApplicableRecruiting
Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage
NCT02382692CompletedPrimary
Cerebrospinal Fluid Rhinorrhea After Functional Endoscopic Sinus Surgery
NCT01295619Not ApplicableCompletedPrimary
Performance and Safety of I-020805 in Prevention of Cerebrospinal Fluid (CSF) Leakage Following Elective Craniotomy
Showing all 5 trials